Nautilus Biotechnology, Inc. Stock Forecast
Evaluation of Nautilus Biotechnology, Inc. stock downgraded after the last trading session.
(Updated on May 02, 2024)
The Nautilus Biotechnology, Inc. stock price fell by -3.96% on the last day (Thursday, 2nd May 2024) from $2.78 to $2.67. During the last trading day the stock fluctuated 5.24% from a day low at $2.67 to a day high of $2.81. The price has been going up and down for this period, and there has been a 14.1% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -40 thousand shares and in total, 67 thousand shares were bought and sold for approximately $179.13 thousand.
The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -9.76% during the next 3 months and, with a 90% probability hold a price between $2.00 and $2.60 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NAUT Signals & Forecast
The Nautilus Biotechnology, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $2.54 and $2.60. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, May 01, 2024, and so far it has fallen -3.96%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Support, Risk & Stop-loss for Nautilus Biotechnology, Inc. stock
Nautilus Biotechnology, Inc. finds support from accumulated volume at $2.56 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.140 between high and low, or 5.24%. For the last week the stock has had daily average volatility of 10.82%.
Our recommended stop-loss: $2.53 (-5.34%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 1 day ago.)
Trading Expectations (NAUT) For The Upcoming Trading Day Of Friday 3rd
For the upcoming trading day on Friday, 3rd we expect Nautilus Biotechnology, Inc. to open at $2.72, and during the day (based on 14 day Average True Range), to move between $2.47 and $2.87, which gives a possible trading interval of +/-$0.204 (+/-7.63%) up or down from last closing price. If Nautilus Biotechnology, Inc. takes out the full calculated possible swing range there will be an estimated 15.27% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $2.69 (0.75%) than the support at $2.56 (4.12%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Nautilus Biotechnology, Inc. stock A Buy?
Nautilus Biotechnology, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.
Current score: -0.794 Hold/Accumulate Downgraded
Predicted Opening Price for Nautilus Biotechnology, Inc. of Friday, May 3, 2024
| Fair opening price May 3, 2024 | Current price |
|---|---|
| $2.72 ( 1.75%) | $2.67 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NAUT
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.86 | 6.99 % | |
| R2 | 2.80 | 4.99 % | ||
| R1 | 2.77 | 3.75 % | ||
| Current price: | 2.67 | |||
| Support | S1 | 2.66 | -0.255 % | |
| S2 | 2.63 | -1.49 % | ||
| S3 | 2.58 | -3.50 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.94 | 10.11 % | |
| R2 | 2.72 | 1.87 % | ||
| R1 | 2.69 | 0.749 % | ||
| Current price | 2.67 | |||
| Support | S1 | 2.56 | -4.12% | |
| S2 | 2.54 | -4.87% | ||
| S3 | 2.41 | -9.74% |
FAQ
Click here for our free guide on how to buy Nautilus Biotechnology, Inc. Stock.
